340B Issues Remain Unresolved in Latest CMS Medicare Drug Price Negotiation Guidance

CMS
CMS said in its latest Medicare Drug Price Negotiation Program guidance it still working on a process to allow manufacturers to avoid providing a 340B price and a negotiated fair price for the same drug.
The latest guidance to implement first-time drug price negotiation under Medicare said federal officials still are looking for a process [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Christopher Cooper, Health Systems Solutions Director, AllianceRx Walgreens Pharmacy

Chris Cooper

Q: Where did you grow up?

I was born and raised in Northwest Indiana and have lived in the Chicago area for the past 25 years.

Q: Where did you go to college/graduate school?

I attended Indiana University where I received my Bachelors in Economics.

Q: What are your favorites?

Food:  Influenced by the NW Indiana farming

Read More »

Top Republican on Senate HELP Committee Calls for 340B Transparency and Accountability Action

Bill Cassidy
U.S. Senate HELP Committee ranking Republican Bill Cassidy (La.) said in an op-ed today that Congress should “increase 340B transparency and accountability to preserve the intent of the program.”
U.S. Sen Bill Cassidy (La.), the top Republican on the Senate Health, Education, Labor, and Pensions Committee, said in an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group Seeking New 340C Program for Grantees and Rural Hospitals Is Ramping Up Advocacy

340C
More than 100 health centers and groups have signed a letter to Congress supporting the 340C initiative.
The national health center group promoting 340C—a proposed alternative to the 340B drug pricing program for health centers, federal grantees, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Tips for Specialty Pharmacy Success

SPONSORED CONTENT

The Origin and Evolution of Specialty Pharmacy

Commencing in the early 1970s, specialty pharmacy was originally intended for patients requiring unique therapies for various conditions. Initially this included mainly infusions for hemophilia, cancer, or malnutrition[i]. Most of these offerings came with

Read More »

NRHA Launches New 340B Policy and Advocacy Campaign

Rural hospital
The National Rural Health Association has intensified its 340B advocacy work with a new congressional campaign and set of policy principles.
The National Rural Health Association has intensified its 340B advocacy work with a new congressional campaign and set of policy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Report Bolsters Editorial Staff with Two Key Hires

Rich and Will
Rich Daly (left) is 340B Report's new editor in chief and Will Newton is its new Washington correspondent. Tom Mirga, top editor since its founding in 2020, is now editor at large.

340B Report, the indispensable source for news and intelligence on the 340B drug pricing program, has added two team members with deep health care journalism experience. Rich Daly, a veteran healthcare business and policy journalist, is 340B Report’s new editor

Read More »

News Alert

UPDATED: Astellas and AstraZeneca Make 340B Contract Pharmacy Moves

Astellas Pharma
Astellas is the third drugmaker to loosen or end its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.
Drug manufacturers Astellas and AstraZeneca announced today separate contract pharmacy policies for 340B providers that will go into effect in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live